Malignant Histiocytic and Dendritic Cell Neoplasm

Malignant Histiocytic and Dendritic Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

82 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 43
Recruiting: 21
Ph III recruiting: 1
Growth YoY: —
Industry share: 14%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03386513	Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN	active not recruiting	Phase 1 / Phase 2	179	AbbVieINDUSTRY	6	Sep 4, 2026	clinicaltrials
NCT02159495	Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm	active not recruiting	Phase 1	31	City of Hope Medical CenterOTHER	1	Aug 26, 2026	clinicaltrials